@article{discovery10184149,
          number = {1},
           month = {March},
         journal = {JAC-Antimicrobial Resistance},
       publisher = {OXFORD UNIV PRESS},
            year = {2021},
           title = {Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK},
            note = {{\copyright} The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.},
          volume = {3},
          author = {Brown, Nicholas M and Goodman, Anna L and Horner, Carolyne and Jenkins, Abi and Brown, Erwin M},
            issn = {2632-1823},
        abstract = {These evidence-based guidelines are an updated version of those issued in 2008. They have beenproduced following a review of the published literature (2007-18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, takinginto account changes in the UK epidemiology of MRSA, ongoing national surveillance data and the efficacy of novel anti-staphylococcal agents licensed for use in the UK. Emerging therapies that have not been licensed for use in the UK at the time of the review have also been assessed.},
             url = {https://doi.org/10.1093/jacamr/dlaa114}
}